OpenURL Connection Search

Select item for more details and to access through your institution.

Stringent Base Specific and Optimization-Free Multiplex Mediator Probe ddPCR for the Quantification of Point Mutations in Circulating Tumor DNA.
Published in:
Cancers, 2021, v. 13, n. 22, p. 5742, doi. 10.3390/cancers13225742
By:
- Schlenker, Franziska;
- Kipf, Elena;
- Deuter, Max;
- Höffkes, Inga;
- Lehnert, Michael;
- Zengerle, Roland;
- von Stetten, Felix;
- Scherer, Florian;
- Wehrle, Julius;
- von Bubnoff, Nikolas;
- Juelg, Peter;
- Hutzenlaub, Tobias;
- Borst, Nadine
Publication type:
Article
Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small‐cell lung cancer.
Published in:
Molecular Oncology, 2022, v. 16, n. 2, p. 527, doi. 10.1002/1878-0261.13116
By:
- Waldeck, Silvia;
- Mitschke, Jan;
- Wiesemann, Sebastian;
- Rassner, Michael;
- Andrieux, Geoffroy;
- Deuter, Max;
- Mutter, Jurik;
- Lüchtenborg, Anne‐Marie;
- Kottmann, Daniel;
- Titze, Laurin;
- Zeisel, Christoph;
- Jolic, Martina;
- Philipp, Ulrike;
- Lassmann, Silke;
- Bronsert, Peter;
- Greil, Christine;
- Rawluk, Justyna;
- Becker, Heiko;
- Isbell, Lisa;
- Müller, Alexandra
Publication type:
Article
Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management.
Published in:
Diagnostics (2075-4418), 2020, v. 10, n. 8, p. 550, doi. 10.3390/diagnostics10080550
By:
- Wehrle, Julius;
- Philipp, Ulrike;
- Jolic, Martina;
- Follo, Marie;
- Hussung, Saskia;
- Waldeck, Silvia;
- Deuter, Max;
- Rassner, Michael;
- Braune, Jan;
- Rawluk, Justyna;
- Greil, Christine;
- Waller, Cornelius F.;
- Becker, Heiko;
- Duque-Afonso, Jesús;
- Illert, Anna L.;
- Fritsch, Ralph M.;
- Meiss, Frank;
- Duyster, Justus;
- von Bubnoff, Nikolas;
- Scherer, Florian
Publication type:
Article

Found: 3

Stringent Base Specific and Optimization-Free Multiplex Mediator Probe ddPCR for the Quantification of Point Mutations in Circulating Tumor DNA.

Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small‐cell lung cancer.

Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management.